We are actively engaging partners for clinical development partnerships and geographical expansion to support patient access. We also are focused on accelerating novel therapeutic discovery and development by reducing screen failure rates and improving clinical trial enrolment, as well as monitoring patient response to therapeutic agents. Please contact us if interested.